» Articles » PMID: 22621234

Interleukin-1β Increases Release of Endothelin-1 and Tumor Necrosis Factor As Well As Reactive Oxygen Species by Peripheral Leukocytes During Experimental Subarachnoid Hemorrhage

Overview
Date 2012 May 25
PMID 22621234
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

In the subarachnoid hemorrhage (SAH) blood mixes with cerebrospinal fluid, what starts immunoinflammatory processes - increased synthesis of proinflammatory cytokines, and formation of reactive oxygen species (ROS), resulting in pre-activation of different populations of peripheral leukocytes. Migration of leukocytes to the brain parenchyma through broken blood brain barrier may produce extra brain tissue injury besides of that resulting from SAH. We examined in adult rats the effect of interleukin-1β (IL-1β) neutralization on secretion of cytokines as well as production of ROS in the course of SAH. SAH was produced by injection of 150 μL of autologous arterial blood into cisterna magna. In 50% of animals, IL-1beta activity was inhibited by intracerebroventricular administration of anti-rat IL-1β antibodies. Ninety minutes or 24 hrs following surgery, blood samples were drawn from the extraorbital plexus and centrifuged to obtain two leukocyte subpopulations - polymorphonuclear (PMN) and mononuclear (MN). The chemiluminescence, a hallmark of ROS synthesis, was measured in PMNs. In supernatants from MNs cultures, concentrations endothelin-1 (ET-1), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were assessed. SAH caused the increase ofn PMNs chemiluminescence as well as the increase of production of ET-1 and TNF-α by MNs but had no influence on IL-6 concentration. Neutralization of IL-1β resulted in significant decrease of chemiluminescence as well as concentration of both ET-1 and TNF-α, while IL-6 concentration was increased. These revealed an important role of IL-1β in the activation of peripheral leukocytes in the course of subarachnoid hemorrhage.

Citing Articles

Interleukin-6: Important Mediator of Vasospasm Following Subarachnoid Hemorrhage.

Lucke-Wold B, Hosaka K, Dodd W, Motwani K, Laurent D, Martinez M Curr Neurovasc Res. 2021; 18(3):364-369.

PMID: 34736380 PMC: 10127255. DOI: 10.2174/1567202618666211104122408.


Effects of stellate ganglion block on early brain injury in patients with subarachnoid hemorrhage: a randomised control trial.

Zhang J, Nie Y, Pang Q, Zhang X, Wang Q, Tang J BMC Anesthesiol. 2021; 21(1):23.

PMID: 33472582 PMC: 7816408. DOI: 10.1186/s12871-020-01215-3.


The Role of Sartans in the Treatment of Stroke and Subarachnoid Hemorrhage: A Narrative Review of Preclinical and Clinical Studies.

Wanderer S, Gruter B, Strange F, Sivanrupan S, Di Santo S, Widmer H Brain Sci. 2020; 10(3).

PMID: 32156050 PMC: 7139942. DOI: 10.3390/brainsci10030153.


Neuroinflammation and Microvascular Dysfunction After Experimental Subarachnoid Hemorrhage: Emerging Components of Early Brain Injury Related to Outcome.

Geraghty J, Davis J, Testai F Neurocrit Care. 2019; 31(2):373-389.

PMID: 31012056 PMC: 6759381. DOI: 10.1007/s12028-019-00710-x.


Crosstalk between the angiotensin and endothelin system in the cerebrovasculature after experimental induced subarachnoid hemorrhage.

Wanderer S, Mrosek J, Vatter H, Seifert V, Konczalla J Neurosurg Rev. 2017; 41(2):539-548.

PMID: 28756589 DOI: 10.1007/s10143-017-0887-z.